Celldex Therapeutics reported $6.63M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.25B 40M Jun/2025
Amgen USD 1.7B 9M Sep/2025
Bristol-Myers Squibb USD 1.79B 76M Sep/2025
Celldex Therapeutics USD 6.63M 546K Sep/2025
Glaxosmithkline GBP 2.91B 817.89M Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025